CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") ("PHARMANIAGA SHARE(S)") INTO 1 PHARMANIAGA SHARE ("CONSOLIDATED SHARE(S)") ("SHARE CONSOLIDATION")

Kindly be advised of the following :

1) The above Company's securities will be traded and quoted "Ex - Consolidation" as from: 08 Jun 2026
2) The last date of lodgment : 09 Jun 2026

Remarks 1: 
Participating Organisations are to take note of the following Share Consolidation exercise by PHARMANIAGA BERHAD.
The Share Consolidation comprises the following:-
CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") ("PHARMANIAGA SHARE(S)") INTO 1 PHARMANIAGA SHARE ("CONSOLIDATED SHARE(S)") ("SHARE CONSOLIDATION")
 

In relation to the Share Consolidation undertaken by PHARMA as a SPEEDS Corporate Exercise, Bursa Malaysia Securities Berhad would like to highlight that:
(a) on or after the Ex-date on 08 Jun 2026, trading of PHARMA shares will be based on the newly adjusted share after the Share Consolidation of PHARMA shares,
(b) on the basis of settlement taking place after 09 Jun 2026 with consolidated PHARMA shares, any entitled shareholder who owns PHARMA shares as at Ex-date may sell only up to the maximum PHARMA shares he expects to receive after the Share Consolidation, i.e. the reduced amount, on or after the Ex-date 08 Jun 2026
 

With the adjustments pursuant to the Share Consolidation effected on PHARMA shareholders' CDS account at the end of the Entitlement Date ("Books Closure   Date"), an entitled PHARMA  shareholder may use the following basis to estimate the maximum number of PHARMA  shares that he may sell from the Ex-date until the Book Closing Date which is from 08 Jun 2026 until 09 Jun 2026.

Number of PHARMA shares that may be                                =              Number of shares held / 5
sold from 08 Jun 2026 until 09 Jun 2026                  (All fractional shares computed should be disregarded)

Illustration:
For example, if Mr X owns or purchases 500 PHARMA shares on cum basis on 05 Jun 2026, his CDS account would still show 500 PHARMA  shares until 09 Jun 2026. However, as a result of the above Share Consolidation exercise, Mr X's 500 PHARMA  shares in his CDS account will be adjusted to 100 PHARMA shares on the night of 09 Jun 2026 which is the Book Closing Date. Therefore, Mr X may, if he so wishes, sells only up to 100 PHARMA  shares on or after the Ex-date i.e. from  08 Jun 2026 onwards.
Participating Organisations are hereby requested to caution all dealers and remisiers that, during the period from 08 Jun 2026 until 09 Jun 2026, they are only entitled to sell the maximum of 1/ 5 of the shares owned before the Ex-date. Participants Organisations are reminded that it is important to caution all dealers and remisiers on the above to prevent the dealers and remisiers from overselling of their client's position

Remarks 2: 
The Share Consolidation involves the consolidation of every 5 existing Pharmaniaga Shares into 1 Consolidated Share as at 5:00 p.m. on 9 June 2026, being the entitlement date for the Share Consolidation.

The actual number of Consolidated Shares to be issued will depend on the issued share capital of Pharmaniaga on the Entitlement Date. Fractional entitlements for the Consolidated Shares arising from the Share Consolidation, if any, shall be disregarded and/or dealt with by the Board of Directors of the Company in its absolute discretion as it may deem fit and expedient and in the best interest of the Company.

The Consolidated Shares will be listed and quoted on the Main Market of Bursa Malaysia Securities Berhad ("Bursa Securities") on 10 June 2026, being the next market day after the Entitlement Date ("Listing Date").

The notices of allotment of the Consolidated Shares will be issued and despatched to the entitled shareholders of Pharmaniaga within 4 market days after the Listing Date.